In Mergermarket, Paul Tomasic, Head of European Healthcare at Houlihan Lokey, discusses how strategic acquirers are continuing to drive European healthcare M&A, even as geopolitical uncertainty weighs on market sentiment.
Mr. Tomasic explains why strategic buyers are well positioned to navigate today’s environment, explores the growing use of bilateral sale processes and longer transaction timelines, and shares his outlook for healthcare M&A, including why he expects stronger sponsor activity to return in 2027.
You can read the article here.